-The Times of India LONDON: Herbal medicines are causing millions in India to develop kidney failure and bladder cancer. In a warning that is bound to cause a fresh row over the quality of Asian herbal medicines, British scientists were due to announce on Tuesday that millions of people in Asia — specially in India and China — might be exposed to the risk of kidney failure and bladder cancer from taking...
More »SEARCH RESULT
Total Matching Records found : 171
The Doctor Only Knows Economics-Lola Nayar and Amba Batra Bakshi
-Outlook This could be the UPA’s worst cut to its beloved aam admi. Healthcare has virtually been handed over to privateers. Not For Those Who Need It Most Govt seems to have abandoned healthcare to the private sector Diagnosing An Ailing Republic 70 per cent of India still lives in the villages, where only two per cent of qualified allopathic doctors are available Due to lack of access to medical care, rural India...
More »Needless hysterectomies on poor women rampant across India: Study -Malathy Iyer
-The Times of India MUMBAI: Is India witnessing a spurt in unnecessary hysterectomies? Data released by international charity organization Oxfam on February 6 says as much. The agency said that unnecessary hysterectomies were being performed in Indian private hospitals to economically exploit poor women as well as government-run insurance schemes. A right to information (RTI) request filed by one of Oxfam's local NGOs in the Dausa district of Rajasthan showed that 258...
More »Pharma MNCs use RTI law to protect market for patented drugs & delay entry of generics
-The Economic Times Pharmaceutical multinationals have begun using the Right to Information law to launch pre-emptive legal action against local generic players to protect the market of patented drugs and delay the entry of low cost generic medicines in the 60,000-crore domestic drug market. MNCs are using such information to sue generic firms even at a stage when their marketing approval is still pending or during the few months' window between the...
More »Centre planning major changes in rules for clinical trials
-The Hindu Drugs Controller must be told of adverse events within 24 hours Under sharp criticism for inadequate monitoring of clinical trials in the country, the Union Government is contemplating major changes in the Drugs & Cosmetics Act, 1940, and its Rules. These would make it mandatory for the Investigator to report all serious adverse events, including deaths, to the Drugs Controller General of India (DGCI), as well as the sponsor and...
More »
